Jump to content

Fusafungine

From Wikipedia, the free encyclopedia
Fusafungine
Clinical data
Other namesFusafungin
AHFS/DrugsInternational Drug Names
ATC code
Identifiers
  • cyclo[N-oxa-DL-valyl-N-methyl-L-valyl-N-oxa-DL-valyl-N-methyl-L-valyl-N-oxa-DL-valyl-N-methyl-L-valyl]
CAS Number
PubChemCID
DrugBank
UNII
KEGG
CompTox Dashboard(EPA)
ECHA InfoCard100.014.306Edit this at Wikidata
Chemical and physical data
FormulaC33H57N3O9
Molar mass639.831g·mol−1
3D model (JSmol)
Melting point125 to 129 °C (257 to 264 °F)
  • CC(C)[C@H]1C(=O)OC(C(=O)N([C@H](C(=O)OC(C(=O)N([C@H](C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C
☒NcheckY(what is this?)(verify)

Fusafungine(INN), also known asfusafungin,is an active agent used inantibioticsfor treatment ofnasalandthroat infection.It also possessesanti-inflammatoryproperties. Fusafungine is a mixture ofenniatincyclohexadepsipeptidesmade up of alternatingD-α-hydroxyvaleric acid andL-N-methylamino acid residues,[1]produced by theascomyceteFusarium lateritium,and marketed byServierunder the trade namesLocabiotal,Bioparox,andLocabiosol.

According to a pooled analysis study done in the UK for the efficacy of fusafungine inrhinopharingitis,it was found that the proportion of patients who showed an improvement in symptoms from Day 0 to Day 4 of infection was 61.5% with fusafungine vs. 46.8% when compared to a placebo.[2]

In February 2016, theEuropean Medicines Agencyrecommended the withdrawal of fusafungine from the market due to rare but severe allergic reactions (mainlybronchospasms).[3]

References

[edit]
  1. ^Levy D, Bluzat A, Seigneuret M, Rigaud JL (December 1995). "Alkali cation transport through liposomes by the antimicrobial fusafungine and its constitutive enniatins".Biochemical Pharmacology.50(12): 2105–7.doi:10.1016/0006-2952(95)02045-4.PMID8849339.
  2. ^Lund VJ, Grouin JM, Eccles R, Bouter C, Chabolle F (December 2004). "Efficacy of fusafungine in acute rhinopharyngitis: a pooled analysis".Rhinology.42(4): 207–12.PMID15626253.
  3. ^"CMDh endorses revocation of authorisations for fusafungine sprays used to treat airway infections".European Medicines Agency. 17 September 2018. Archived fromthe originalon 20 June 2018.Retrieved18 February2022.